Concentration-dependent bifunctional effect of TGF-β1 on immunoglobulin production: A role for Smad3 in IgA production in vitro

International Immunopharmacology

Volumn 3, Issue 13-14, 2003, Pages 1761-1774

  McKarns, Susan C ^a,b   Letterio, John J ^b   Kaminski, Norbert E ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Immunoglobulin; Smad3; TGF 1

Indexed keywords

IMMUNOGLOBULIN A; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC CODE; IMMUNE RESPONSE; IMMUNOGLOBULIN PRODUCTION; IMMUNOMODULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SPLEEN CELL; WILD TYPE;

EID: 0242543345     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2003.08.001     Document Type: Article

References (50)

1. Letterio J.J., Roberts A.B. Regulation of immune responses by TGF-beta. Annu. Rev. Immunol. 16:1998;137-161.
2. Lawrence D.A. Transforming growth factor-beta: a general review. Eur. Cytokine Netw. 7(3):1996;363-374.
3. Dunker N., Krieglstein K. Targeted mutations of transforming growth factor-beta genes reveal important roles in mouse development and adult homeostasis. Eur. J. Biochem. 267(24):2000;6982-6988.
4. McCartney-Francis N.L., Frazier-Jessen M., Wahl S.M. TGF-beta: a balancing act. Int. Rev. Immunol. 16(5-6):1998;553-580.
5. Letterio J.J. Murine models define the role of TGF-beta as a master regulator of immune cell function. Cytokine Growth Factor Rev. 11(1-2):2000;81-87.
6. Jin Y.X., Xu L.Y., Guo H., Ishikawa M., Link H., Xiao B.G. TGF-beta1 inhibits protracted-relapsing experimental autoimmune encephalomyelitis by activating dendritic cells. J. Autoimmun. 14(3):2000;213-220.
7. Santambrogio L., Hochwald G.M., Leu C.H., Thorbecke G.J. Antagonistic effects of endogenous and exogenous TGF-beta and TNF on auto-immune diseases in mice. Immunopharmacol. Immunotoxicol. 15(4):1993;461-478.
8. Johns L.D., Sriram S. Experimental allergic encephalomyelitis: neutralizing antibody to TGF beta 1 enhances the clinical severity of the disease. J. Neuroimmunol. 47(1):1993;1-7.
9. Santambrogio L., Hochwald G.M., Saxena B., Leu C.H., Martz J.E., Carlino J.A., et al. Studies on the mechanisms by which transforming growth factor-beta (TGF-beta) protects against allergic encephalomyelitis. Antagonism between TGF-beta and tumor necrosis factor. J. Immunol. 151(2):1993;1116-1127.
10. Wahl S.M., Hunt D.A., Wakefield L.M., McCartney-Francis N., Wahl L.M., Roberts A.B., et al. Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc. Natl. Acad. Sci. U. S. A. 84(16):1987;5788-5792.
11. Kehrl J.H., Wakefield L.M., Roberts A.B., Jakowlew S., Alvarez-Mon M., Derynck R., et al. Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J. Exp. Med. 163(5):1986;1037-1050.
12. Brodin G., Ahgren A., ten Dijke P., Heldin C.H., Heuchel R. Efficient TGF-beta induction of the Smad7 gene requires cooperation between AP-1, Sp1, and Smad proteins on the mouse Smad7 promoter. J. Biol. Chem. 275(37):2000;29023-29030.
13. Massague J., Chen Y.G. Controlling TGF-beta signaling. Genes Dev. 14(6):2000;627-644.
14. Massague J., Wotton D. Transcriptional control by the TGF-beta/Smad signaling system. Embo J. 19(8):2000;1745-1754.
15. Verschueren K., Huylebroeck D. Remarkable versatility of Smad proteins in the nucleus of transforming growth factor-beta activated cells. Cytokine Growth Factor Rev. 10(3-4):1999;187-199.
16. Kulkarni A.B., Huh C.G., Becker D., Geiser A., Lyght M., Flanders K.C., et al. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. U. S. A. 90(2):1993;770-774.
17. Christ M., McCartney-Francis N.L., Kulkarni A.B., Ward J.M., Mizel D.E., Mackall C.L., et al. Immune dysregulation in TGF-beta 1-deficient mice. J. Immunol. 153(5):1994;1936-1946.
18. Diebold R.J., Eis M.J., Yin M., Ormsby I., Boivin G.P., Darrow B.J., et al. Early-onset multifocal inflammation in the transforming growth factor beta 1-null mouse is lymphocyte mediated. Proc. Natl. Acad. Sci. U. S. A. 92(26):1995;12215-12219.
19. Gorelik L., Flavell R.A. Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity. 12(2):2000;171-181.
20. Cazac B.B., Roes J. TGF-beta receptor controls B cell responsiveness and induction of IgA in vivo. Immunity. 13(4):2000;443-451.
21. Kamesaki H., Nishizawa K., Michaud G.Y., Cossman J., Kiyono T. TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells. J. Immunol. 160(2):1998;770-777.
22. Holder M.J., Knox K., Gordon J. Factors modifying survival pathways of germinal center B cells. Glucocorticoids and transforming growth factor-beta, but not cyclosporin A or anti-CD19, block surface immunoglobulin-mediated rescue from apoptosis. Eur. J. Immunol. 22(10):1992;2725-2728.
23. Lomo J., Blomhoff H.K., Beiske K., Stokke T., Smeland E.B. TGF-beta 1 and cyclic AMP promote apoptosis in resting human B lymphocytes. J. Immunol. 154(4):1995;1634-1643.
24. Coffman R.L., Lebman D.A., Shrader B. Transforming growth factor beta specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes. J. Exp. Med. 170(3):1989;1039-1044.
25. Stavnezer J. Regulation of antibody production and class switching by TGF-beta. J. Immunol. 155(4):1995;1647-1651.
26. Shi M.J., Park S.R., Kim P.H., Stavnezer J. Roles of Ets proteins, NF-kappaB and nocodazole in regulating induction of transcription of mouse germline Ig alpha RNA by transforming growth factor-beta1. Int. Immunol. 13(6):2001;733-746.
27. Zhang Y., Derynck R. Transcriptional regulation of the transforming growth factor-beta-inducible mouse germ line Ig alpha constant region gene by functional cooperation of Smad, CREB, and AML family members. J. Biol. Chem. 275(22):2000;16979-16985.
28. Park S.R., Lee J.H., Kim P.H. Smad3 and Smad4 mediate transforming growth factor-beta1-induced IgA expression in murine B lymphocytes. Eur. J. Immunol. 31(6):2001;1706-1715.
29. Pardali E., Xie X.Q., Tsapogas P., Itoh S., Arvanitidis K., Heldin C.H., et al. Smad and AML proteins synergistically confer transforming growth factor beta1 responsiveness to human germ-line IgA genes. J. Biol. Chem. 275(5):2000;3552-3560.
30. Yang X., Letterio J.J., Lechleider R.J., Chen L., Hayman R., Gu H., et al. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta. Embo J. 18(5):1999;1280-1291.
31. Datto M.B., Frederick J.P., Pan L., Borton A.J., Zhuang Y., Wang X.F. Targeted disruption of Smad3 reveals an essential role in transforming growth factor beta-mediated signal transduction. Mol. Cell. Biol. 19(4):1999;2495-2504.
32. Kaminski N.E., Stevens W.D. The role of metabolism in carbon tetrachloride-mediated immunosuppression. In vitro studies. Toxicology. 75(2):1992;175-188.
33. Delaney B., Strom S.C., Collins S., Kaminski N.E. Carbon tetrachloride suppresses T-cell-dependent immune responses by induction of transforming growth factor-beta 1. Toxicol. Appl. Pharmacol. 126(1):1994;98-107.
34. McKarns S.C., Kaminski N.E. TGF-beta 1 differentially regulates IL-2 expression and [3H]-thymidine incorporation in CD3 epsilon mAb- and CD28 mAb-activated splenocytes and thymocytes. Immunopharmacology. 48(2):2000;101-115.
35. Dong Y., Tang L., Letterio J.J., Benveniste E.N. The smad3 protein is involved in tgf-beta inhibition of class ii transactivator and class ii mhc expression. J. Immunol. 167(1):2001;311-319.
36. Kaminski N.E., Jordan S.D., Holsapple M.P. Suppression of humoral and cell-mediated immune responses by carbon tetrachloride. Fundam. Appl. Toxicol. 12(1):1989;117-128.
37. Kaminski N.E., Barnes D.W., Jordan S.D., Holsapple M.P. The role of metabolism in carbon tetrachloride-mediated immunosuppression: in vivo studies. Toxicol. Appl. Pharmacol. 102(1):1990;9-20.
38. Neuman M.G. Apoptosis in diseases of the liver. Crit. Rev. Clin. Lab. Sci. 38(2):2001;109-166.
39. Gutierrez-Ruiz M.C., Gomez Quiroz L.E., Hernandez E., Bucio L., Souza V., Llorente L., et al. Cytokine response and oxidative stress produced by ethanol, acetaldehyde and endotoxin treatment in HepG2 cells. Isr. Med. Assoc. J. 3(2):2001;131-136.
40. Simile M.M., Banni S., Angioni E., Carta G., De Miglio M.R., Muroni M.R., et al. 5′-Methylthioadenosine administration prevents lipid peroxidation and fibrogenesis induced in rat liver by carbon-tetrachloride intoxication. J. Hepatol. 34(3):2001;386-394.
41. Yin M., Bradford B.U., Wheeler M.D., Uesugi T., Froh M., Goyert S.M., et al. Reduced early alcohol-induced liver injury in cd14-deficient mice. J. Immunol. 166(7):2001;4737-4742.
42. He J., Xin S., Zhao J., Wang S. The expression of transforming growth factor-beta receptor I and its mRNA in liver tissues of chronic hepatitis B and the clinical significance. Zhonghua Ganzangbing Zazhi. 8(6):2000;340-342.
43. Szuster-Ciesielska A., Daniluk J., Kandefer-Zerszen M. Serum levels of cytokines in alcoholic liver cirrhosis and pancreatitis. Arch. Immunol. Ther. Exp. 48(4):2000;301-307.
44. Inoue K., Sugawara Y., Kubota K., Takayama T., Makuuchi M. Induction of type 1 plasminogen activator inhibitor in human liver ischemia and reperfusion. J. Hepatol. 33(3):2000;407-414.
45. Hori Y., Takeyama Y., Ueda T., Shinkai M., Takase K., Kuroda Y. Macrophage-derived transforming growth factor-beta1 induces hepatocellular injury via apoptosis in rat severe acute pancreatitis. Surgery. 127(6):2000;641-649.
46. Vodovotz Y., Lucia M.S., DeLucca A.M., Mitchell J.B., Kopp J.B. Reduced hematopoietic function and enhanced radiosensitivity of transforming growth factor-beta1 transgenic mice. Int. J. Cancer. 90(1):2000;13-21.
47. Lemmer E.R., de la Motte Hall P., Omori N., Omori M., Shephard E.G., Gelderblom W.C., et al. Histopathology and gene expression changes in rat liver during feeding of fumonisin B1, a carcinogenic mycotoxin produced by Fusarium moniliforme. Carcinogenesis. 20(5):1999;817-824.
48. Ahuja S.S., Shrivastav S., Danielpour D., Balow J.E., Boumpas D.T. Regulation of transforming growth factor-beta 1 and its receptor by cyclosporine in human T lymphocytes. Transplantation. 60(7):1995;718-723.
49. Massague J. TGF-beta signal transduction. Annu. Rev. Biochem. 67:1998;753-791.
50. Hiroi T., Yanagita M., Ohta N., Sakaue G., Kiyono H. IL-15 and IL-15 receptor selectively regulate differentiation of common mucosal immune system-independent B-1 cells for IgA responses. J. Immunol. 165(8):2000;4329- 4337.